1. Home
  2. CRL vs NICE Comparison

CRL vs NICE Comparison

Compare CRL & NICE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRL
  • NICE
  • Stock Information
  • Founded
  • CRL 1947
  • NICE 1986
  • Country
  • CRL United States
  • NICE Israel
  • Employees
  • CRL N/A
  • NICE N/A
  • Industry
  • CRL Biotechnology: Commercial Physical & Biological Resarch
  • NICE Computer Software: Prepackaged Software
  • Sector
  • CRL Health Care
  • NICE Technology
  • Exchange
  • CRL Nasdaq
  • NICE Nasdaq
  • Market Cap
  • CRL 9.8B
  • NICE 11.1B
  • IPO Year
  • CRL 2000
  • NICE 1996
  • Fundamental
  • Price
  • CRL $186.29
  • NICE $175.42
  • Analyst Decision
  • CRL Hold
  • NICE Strong Buy
  • Analyst Count
  • CRL 13
  • NICE 14
  • Target Price
  • CRL $211.64
  • NICE $259.50
  • AVG Volume (30 Days)
  • CRL 531.0K
  • NICE 358.0K
  • Earning Date
  • CRL 02-12-2025
  • NICE 11-14-2024
  • Dividend Yield
  • CRL N/A
  • NICE N/A
  • EPS Growth
  • CRL N/A
  • NICE 31.21
  • EPS
  • CRL 8.00
  • NICE 6.47
  • Revenue
  • CRL $4,060,916,000.00
  • NICE $2,636,864,000.00
  • Revenue This Year
  • CRL N/A
  • NICE $17.10
  • Revenue Next Year
  • CRL $1.18
  • NICE $11.06
  • P/E Ratio
  • CRL $23.28
  • NICE $25.95
  • Revenue Growth
  • CRL N/A
  • NICE 13.52
  • 52 Week Low
  • CRL $176.48
  • NICE $151.52
  • 52 Week High
  • CRL $275.00
  • NICE $270.73
  • Technical
  • Relative Strength Index (RSI)
  • CRL 42.96
  • NICE 43.52
  • Support Level
  • CRL $180.21
  • NICE $172.21
  • Resistance Level
  • CRL $188.04
  • NICE $191.66
  • Average True Range (ATR)
  • CRL 6.14
  • NICE 6.16
  • MACD
  • CRL -1.04
  • NICE -1.75
  • Stochastic Oscillator
  • CRL 27.01
  • NICE 15.06

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

About NICE NICE Ltd

Nice is an enterprise software company that serves the customer engagement and financial crime and compliance markets. The company provides data analytics-based solutions through both a cloud platform and on-premises infrastructure. Within customer engagement, Nice's CXone platform delivers solutions focused on contact center software and workforce engagement management, or WEM. Contact center offerings include solutions for digital self-service, customer journey and experience optimization, and compliance. WEM products optimize call center efficiency, leveraging data and AI analytics for call volume forecasting and agent scheduling. Within financial crime and compliance, Nice offers risk and investigation management, fraud prevention, anti-money laundering, and compliance solutions.

Share on Social Networks: